Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-23-005769

Chief Executive Officer sold 25,000 shares at an average $51.47 ($1,286,798)

  • Chief Executive Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2023-01-27 Option exercise +25,000 $19.12 $478,000 394,111 D
Kulkarni Samarth Chief Executive Officer 2023-01-27 Sale −1,800 $50.60 $91,086 392,311 D
Kulkarni Samarth Chief Executive Officer 2023-01-27 Sale −23,200 $51.54 $1,195,712 369,111 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2023-01-27 Option exercise · Stock Option (Right to Buy) −25,000 179,582 D
Open-market sales · 25,000 sh · avg $51.47 · $1,286,798
Loading xslF345X03/doc4.xml…